How to reduce TAVI-related conduction abnormalities during the COVID-19 pandemic

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

Interventional cardiologist in University Hospital Düsseldorf, Germany. Senior consultatnt since 2007 joining the TAVI team in 2010 and in charge of the transcatheter valve implantation program since 2014.

A senior consultant cardiologist at University Hospital Dusseldorf, Dusseldorf, Germany. Features in 2 videos on Wondr Medical. Verena Veulemans generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Covid-19, and Covid19 Webinars and Discussions.